Status:
COMPLETED
Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
Takeda Pharmaceuticals North America, Inc.
Conditions:
Chronic Idiopathic Constipation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This prospective study is designed to evaluate how lubiprostone may affect gastric motor and sensory function.
Eligibility Criteria
Inclusion
- chronic idiopathic constipation
Exclusion
- medications that slow gastrointestinal (GI) motility
- prior surgery to the GI tract
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01460225
Start Date
September 1 2007
End Date
January 1 2011
Last Update
July 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756